HSDT
vs
S&P 500
HSDT
S&P 500
Over the past 12 months, HSDT has underperformed S&P 500, delivering a return of -100% compared to the S&P 500's +14% growth.
Stocks Performance
HSDT vs S&P 500
Performance Gap
HSDT vs S&P 500
Performance By Year
HSDT vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Helius Medical Technologies Inc
Glance View
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania. The company went IPO on 2014-06-27. The firm focuses on developing, licensing or acquiring non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The firm's product, Portable Neuromodulation Stimulator (PoNS) is a class II, non-implantable medical device intended for use as a short-term treatment (14 weeks) of gait deficit due to symptoms from multiple sclerosis (MS), and balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with supervised therapeutic exercise (PoNS Treatment). The firm's subsidiaries include Helius Medical, Inc., Helius Medical Technologies (Canada), Inc., Helius NeuroRehab, Inc., Helius Canada Acquisition Ltd. and Heuro Canada, Inc.